The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Veterinary Vaccine Adjuvants-Global Market Insights and Sales Trends 2025
Synopsis
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The global Veterinary Vaccine Adjuvants market size is expected to reach US$ 485.1 million by 2029, growing at a CAGR of 6.9% from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Vaccine Adjuvants in various end use industries. The expanding demands from the Livestock Vaccines and Companion Animals Vaccines, are propelling Veterinary Vaccine Adjuvants market. Emulsion Adjuvants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mineral Adjuvants segment is estimated at % CAGR for the next seven-year period.
Global 5 largest manufacturers of Veterinary Vaccine Adjuvants are SEPPIC, Croda, Vertellus, SPI Pharma and SDA BIO, which make up about 70%. Among them, SEPPIC is the leader with about 35% market share.
North America is the largest market, with a share over 30%, followed by Asia-Pacific and Europe, with the share about 30% and 22%. In terms of product type, Emulsion Adjuvants occupy the largest share of the total market, about 58%. And in terms of application, the largest application is Livestock Vaccines, followed by Companion Animals Vaccines.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Vaccine Adjuvants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Vaccine Adjuvants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Vaccine Adjuvants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Vaccine Adjuvants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Vaccine Adjuvants covered in this report include SEPPIC, SDA BIO, Croda, SPI Pharma, Phibro Animal Health and Vertellus, etc.
The global Veterinary Vaccine Adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
SEPPIC
SDA BIO
Croda
SPI Pharma
Phibro Animal Health
Vertellus
Global Veterinary Vaccine Adjuvants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Vaccine Adjuvants market, Segment by Type:
Emulsion Adjuvants
Mineral Adjuvants
Others
Global Veterinary Vaccine Adjuvants market, by Application
Livestock Vaccines
Companion Animals Vaccines
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Veterinary Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Veterinary Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The global Veterinary Vaccine Adjuvants market size is expected to reach US$ 485.1 million by 2029, growing at a CAGR of 6.9% from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Vaccine Adjuvants in various end use industries. The expanding demands from the Livestock Vaccines and Companion Animals Vaccines, are propelling Veterinary Vaccine Adjuvants market. Emulsion Adjuvants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mineral Adjuvants segment is estimated at % CAGR for the next seven-year period.
Global 5 largest manufacturers of Veterinary Vaccine Adjuvants are SEPPIC, Croda, Vertellus, SPI Pharma and SDA BIO, which make up about 70%. Among them, SEPPIC is the leader with about 35% market share.
North America is the largest market, with a share over 30%, followed by Asia-Pacific and Europe, with the share about 30% and 22%. In terms of product type, Emulsion Adjuvants occupy the largest share of the total market, about 58%. And in terms of application, the largest application is Livestock Vaccines, followed by Companion Animals Vaccines.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Vaccine Adjuvants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Vaccine Adjuvants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Vaccine Adjuvants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Vaccine Adjuvants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Vaccine Adjuvants covered in this report include SEPPIC, SDA BIO, Croda, SPI Pharma, Phibro Animal Health and Vertellus, etc.
The global Veterinary Vaccine Adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
SEPPIC
SDA BIO
Croda
SPI Pharma
Phibro Animal Health
Vertellus
Global Veterinary Vaccine Adjuvants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Vaccine Adjuvants market, Segment by Type:
Emulsion Adjuvants
Mineral Adjuvants
Others
Global Veterinary Vaccine Adjuvants market, by Application
Livestock Vaccines
Companion Animals Vaccines
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Veterinary Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Veterinary Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Veterinary Vaccine Adjuvants Market Overview
1.1 Veterinary Vaccine Adjuvants Product Overview
1.2 Veterinary Vaccine Adjuvants Market Segment by Type
1.2.1 Emulsion Adjuvants
1.2.2 Mineral Adjuvants
1.2.3 Others
1.3 Global Veterinary Vaccine Adjuvants Market Size by Type
1.3.1 Global Veterinary Vaccine Adjuvants Market Size Overview by Type (2018-2029)
1.3.2 Global Veterinary Vaccine Adjuvants Historic Market Size Review by Type (2018-2023)
1.3.3 Global Veterinary Vaccine Adjuvants Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Veterinary Vaccine Adjuvants Sales Breakdown by Type (2018-2023)
1.4.2 Europe Veterinary Vaccine Adjuvants Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Veterinary Vaccine Adjuvants Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Veterinary Vaccine Adjuvants Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Veterinary Vaccine Adjuvants Sales Breakdown by Type (2018-2023)
2 Global Veterinary Vaccine Adjuvants Market Competition by Company
2.1 Global Top Players by Veterinary Vaccine Adjuvants Sales (2018-2023)
2.2 Global Top Players by Veterinary Vaccine Adjuvants Revenue (2018-2023)
2.3 Global Top Players by Veterinary Vaccine Adjuvants Price (2018-2023)
2.4 Global Top Manufacturers Veterinary Vaccine Adjuvants Manufacturing Base Distribution, Sales Area, Product Type
2.5 Veterinary Vaccine Adjuvants Market Competitive Situation and Trends
2.5.1 Veterinary Vaccine Adjuvants Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Veterinary Vaccine Adjuvants Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Vaccine Adjuvants as of 2022)
2.7 Date of Key Manufacturers Enter into Veterinary Vaccine Adjuvants Market
2.8 Key Manufacturers Veterinary Vaccine Adjuvants Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Veterinary Vaccine Adjuvants Status and Outlook by Region
3.1 Global Veterinary Vaccine Adjuvants Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Veterinary Vaccine Adjuvants Historic Market Size by Region
3.2.1 Global Veterinary Vaccine Adjuvants Sales in Volume by Region (2018-2023)
3.2.2 Global Veterinary Vaccine Adjuvants Sales in Value by Region (2018-2023)
3.2.3 Global Veterinary Vaccine Adjuvants Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Veterinary Vaccine Adjuvants Forecasted Market Size by Region
3.3.1 Global Veterinary Vaccine Adjuvants Sales in Volume by Region (2024-2029)
3.3.2 Global Veterinary Vaccine Adjuvants Sales in Value by Region (2024-2029)
3.3.3 Global Veterinary Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Veterinary Vaccine Adjuvants by Application
4.1 Veterinary Vaccine Adjuvants Market Segment by Application
4.1.1 Livestock Vaccines
4.1.2 Companion Animals Vaccines
4.2 Global Veterinary Vaccine Adjuvants Market Size by Application
4.2.1 Global Veterinary Vaccine Adjuvants Market Size Overview by Application (2018-2029)
4.2.2 Global Veterinary Vaccine Adjuvants Historic Market Size Review by Application (2018-2023)
4.2.3 Global Veterinary Vaccine Adjuvants Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Veterinary Vaccine Adjuvants Sales Breakdown by Application (2018-2023)
4.3.2 Europe Veterinary Vaccine Adjuvants Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Veterinary Vaccine Adjuvants Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Veterinary Vaccine Adjuvants Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Veterinary Vaccine Adjuvants Sales Breakdown by Application (2018-2023)
5 North America Veterinary Vaccine Adjuvants by Country
5.1 North America Veterinary Vaccine Adjuvants Historic Market Size by Country
5.1.1 North America Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Veterinary Vaccine Adjuvants Sales in Volume by Country (2018-2023)
5.1.3 North America Veterinary Vaccine Adjuvants Sales in Value by Country (2018-2023)
5.2 North America Veterinary Vaccine Adjuvants Forecasted Market Size by Country
5.2.1 North America Veterinary Vaccine Adjuvants Sales in Volume by Country (2024-2029)
5.2.2 North America Veterinary Vaccine Adjuvants Sales in Value by Country (2024-2029)
6 Europe Veterinary Vaccine Adjuvants by Country
6.1 Europe Veterinary Vaccine Adjuvants Historic Market Size by Country
6.1.1 Europe Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Veterinary Vaccine Adjuvants Sales in Volume by Country (2018-2023)
6.1.3 Europe Veterinary Vaccine Adjuvants Sales in Value by Country (2018-2023)
6.2 Europe Veterinary Vaccine Adjuvants Forecasted Market Size by Country
6.2.1 Europe Veterinary Vaccine Adjuvants Sales in Volume by Country (2024-2029)
6.2.2 Europe Veterinary Vaccine Adjuvants Sales in Value by Country (2024-2029)
7 Asia-Pacific Veterinary Vaccine Adjuvants by Region
7.1 Asia-Pacific Veterinary Vaccine Adjuvants Historic Market Size by Region
7.1.1 Asia-Pacific Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Veterinary Vaccine Adjuvants Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Veterinary Vaccine Adjuvants Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Veterinary Vaccine Adjuvants Forecasted Market Size by Region
7.2.1 Asia-Pacific Veterinary Vaccine Adjuvants Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Veterinary Vaccine Adjuvants Sales in Value by Region (2024-2029)
8 Latin America Veterinary Vaccine Adjuvants by Country
8.1 Latin America Veterinary Vaccine Adjuvants Historic Market Size by Country
8.1.1 Latin America Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Veterinary Vaccine Adjuvants Sales in Volume by Country (2018-2023)
8.1.3 Latin America Veterinary Vaccine Adjuvants Sales in Value by Country (2018-2023)
8.2 Latin America Veterinary Vaccine Adjuvants Forecasted Market Size by Country
8.2.1 Latin America Veterinary Vaccine Adjuvants Sales in Volume by Country (2024-2029)
8.2.2 Latin America Veterinary Vaccine Adjuvants Sales in Value by Country (2024-2029)
9 Middle East and Africa Veterinary Vaccine Adjuvants by Country
9.1 Middle East and Africa Veterinary Vaccine Adjuvants Historic Market Size by Country
9.1.1 Middle East and Africa Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Veterinary Vaccine Adjuvants Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Veterinary Vaccine Adjuvants Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Veterinary Vaccine Adjuvants Forecasted Market Size by Country
9.2.1 Middle East and Africa Veterinary Vaccine Adjuvants Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Veterinary Vaccine Adjuvants Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 SEPPIC
10.1.1 SEPPIC Company Information
10.1.2 SEPPIC Introduction and Business Overview
10.1.3 SEPPIC Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.1.4 SEPPIC Veterinary Vaccine Adjuvants Products Offered
10.1.5 SEPPIC Recent Development
10.2 SDA BIO
10.2.1 SDA BIO Company Information
10.2.2 SDA BIO Introduction and Business Overview
10.2.3 SDA BIO Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.2.4 SDA BIO Veterinary Vaccine Adjuvants Products Offered
10.2.5 SDA BIO Recent Development
10.3 Croda
10.3.1 Croda Company Information
10.3.2 Croda Introduction and Business Overview
10.3.3 Croda Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Croda Veterinary Vaccine Adjuvants Products Offered
10.3.5 Croda Recent Development
10.4 SPI Pharma
10.4.1 SPI Pharma Company Information
10.4.2 SPI Pharma Introduction and Business Overview
10.4.3 SPI Pharma Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.4.4 SPI Pharma Veterinary Vaccine Adjuvants Products Offered
10.4.5 SPI Pharma Recent Development
10.5 Phibro Animal Health
10.5.1 Phibro Animal Health Company Information
10.5.2 Phibro Animal Health Introduction and Business Overview
10.5.3 Phibro Animal Health Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Phibro Animal Health Veterinary Vaccine Adjuvants Products Offered
10.5.5 Phibro Animal Health Recent Development
10.6 Vertellus
10.6.1 Vertellus Company Information
10.6.2 Vertellus Introduction and Business Overview
10.6.3 Vertellus Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Vertellus Veterinary Vaccine Adjuvants Products Offered
10.6.5 Vertellus Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Veterinary Vaccine Adjuvants Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Veterinary Vaccine Adjuvants Industrial Chain Analysis
11.4 Veterinary Vaccine Adjuvants Market Dynamics
11.4.1 Veterinary Vaccine Adjuvants Industry Trends
11.4.2 Veterinary Vaccine Adjuvants Market Drivers
11.4.3 Veterinary Vaccine Adjuvants Market Challenges
11.4.4 Veterinary Vaccine Adjuvants Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Veterinary Vaccine Adjuvants Distributors
12.3 Veterinary Vaccine Adjuvants Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
